John M. Sheldon

791 total citations
28 papers, 349 citations indexed

About

John M. Sheldon is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Allergy and Surgery. According to data from OpenAlex, John M. Sheldon has authored 28 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Immunology and Allergy and 4 papers in Surgery. Recurrent topics in John M. Sheldon's work include Allergic Rhinitis and Sensitization (5 papers), Contact Dermatitis and Allergies (4 papers) and Neuroblastoma Research and Treatments (4 papers). John M. Sheldon is often cited by papers focused on Allergic Rhinitis and Sensitization (5 papers), Contact Dermatitis and Allergies (4 papers) and Neuroblastoma Research and Treatments (4 papers). John M. Sheldon collaborates with scholars based in United States, United Kingdom and Canada. John M. Sheldon's co-authors include Kenneth P. Mathews, Thomas E. Merchant, Steven A. Leibel, Brian J. Davis, Laura A. Siminoff, John H. Fetting, James A. McLean, Brian H. Kushner, Michael J. Zeléfsky and Louis B. Harrison and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American Geriatrics Society.

In The Last Decade

John M. Sheldon

24 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Sheldon United States 9 120 105 94 73 45 28 349
Sanju Cyriac India 8 37 0.3× 81 0.8× 57 0.6× 36 0.5× 53 1.2× 22 343
Janice Mooney United Kingdom 7 180 1.5× 85 0.8× 210 2.2× 24 0.3× 33 0.7× 14 381
F Jost Switzerland 5 77 0.6× 38 0.4× 15 0.2× 63 0.9× 26 0.6× 6 347
Sue Brown United Kingdom 8 234 1.9× 27 0.3× 28 0.3× 47 0.6× 59 1.3× 12 543
A Canevari Italy 11 37 0.3× 120 1.1× 38 0.4× 90 1.2× 17 0.4× 22 355
T. Braun Germany 12 208 1.7× 43 0.4× 32 0.3× 29 0.4× 118 2.6× 25 456
A. Clarke Canada 9 183 1.5× 17 0.2× 40 0.4× 60 0.8× 13 0.3× 15 332
M.L. te Winkel Netherlands 15 86 0.7× 50 0.5× 66 0.7× 30 0.4× 96 2.1× 25 764
Carole Desthieux France 6 272 2.3× 27 0.3× 19 0.2× 55 0.8× 25 0.6× 9 372
Vasiliki Galanopoulou Greece 14 237 2.0× 10 0.1× 68 0.7× 111 1.5× 65 1.4× 23 641

Countries citing papers authored by John M. Sheldon

Since Specialization
Citations

This map shows the geographic impact of John M. Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Sheldon more than expected).

Fields of papers citing papers by John M. Sheldon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Sheldon. The network helps show where John M. Sheldon may publish in the future.

Co-authorship network of co-authors of John M. Sheldon

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Sheldon. A scholar is included among the top collaborators of John M. Sheldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Sheldon. John M. Sheldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woolnough, Kerry, et al.. (2009). An audit of SCLC patients not receiving chemotherapy. Lung Cancer. 63. S10–S10. 1 indexed citations
2.
Ward‐Smith, Peggy, et al.. (2004). Quality of life among men treated with brachytherapy for prostate cancer.. PubMed. 24(2). 95–9. 3 indexed citations
3.
Merchant, Thomas E., Brian H. Kushner, John M. Sheldon, Michael P. LaQuaglia, & John H. Healey. (1999). Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Medical and Pediatric Oncology. 33(2). 65–70. 26 indexed citations
4.
Kresl, John J., et al.. (1999). The employment status of 1995 graduates from radiation oncology training programs in the United States. International Journal of Radiation Oncology*Biology*Physics. 43(5). 1075–1081. 14 indexed citations
5.
Merchant, Thomas E., et al.. (1998). High-dose rate intraoperative radiation therapy for pediatric solid tumors. Medical and Pediatric Oncology. 30(1). 34–39. 29 indexed citations
6.
Merchant, Thomas E., Brian J. Davis, John M. Sheldon, & Steven A. Leibel. (1998). Radiation therapy for relapsed CNS germinoma after primary chemotherapy.. Journal of Clinical Oncology. 16(1). 204–209. 46 indexed citations
7.
Sheldon, John M., Kenneth Forster, L.B. Harrison, et al.. (1997). 1043 Dose escalation for maxillary sinus cancer using intensity-modulated radiation therapy (IMRT). International Journal of Radiation Oncology*Biology*Physics. 39(2). 237–237. 3 indexed citations
8.
Lee, Henry J., Kenneth Forster, John M. Sheldon, et al.. (1997). 29 Mixed modality intensity-modulated radiation therapy treatment planning for intracranial lesions. International Journal of Radiation Oncology*Biology*Physics. 39(2). 149–149. 3 indexed citations
10.
Zeléfsky, Michael J., et al.. (1996). 17 High-dose rate intra-operative radiation therapy for pediatric solid tumors. Radiotherapy and Oncology. 39. S5–S5. 2 indexed citations
11.
Sheldon, John M., John H. Fetting, & Laura A. Siminoff. (1993). Offering the Option of Randomized Clinical Trials to Cancer Patients Who Overestimate Their Prognoses with Standard Therapies. Cancer Investigation. 11(1). 57–62. 26 indexed citations
12.
McLean, James A., et al.. (1964). Some untoward reactions to repository therapy. Journal of Allergy. 35(1). 52–61. 1 indexed citations
13.
Vanselow, Neal A., et al.. (1964). Repository Therapy in Allergic Respiratory Disease. Postgraduate Medicine. 35(2). 165–174.
14.
McLean, James A., et al.. (1961). A study of relationships between family situation, bronchial asthma, and personal adjustment in children. The Journal of Pediatrics. 59(3). 402–414. 42 indexed citations
15.
Sheldon, John M. & E. Wendell Hewson. (1957). Atmospheric pollution by aeroallergens : progress report no. 5 (1 September 1960 to 28 February 1962). Deep Blue (University of Michigan). 27(5). 1117–27, quiz 1128. 1 indexed citations
16.
Mathews, Kenneth P., et al.. (1956). A controlled study on the use of parenteral and oral antihistamines in preventing penicillin reactions. Journal of Allergy. 27(1). 1–15. 25 indexed citations
17.
Mathews, Kenneth P., et al.. (1955). Dermatitis venenata from tree pollen oils. Journal of Allergy. 26(5). 408–414. 2 indexed citations
18.
Sheldon, John M.. (1953). The Place of Antihistaminics in the Treatment of Allergic Disorders. Postgraduate Medicine. 14(6). 465–469.
19.
Pringle, Ross B., et al.. (1951). Bronchial asthma, urticaria, and allergic rhinitis from tannic acid. Journal of Allergy. 22(6). 494–499. 10 indexed citations
20.
Sheldon, John M.. (1951). AEROSOL THERAPY. Journal of the American Medical Association. 146(7). 648–648. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026